Acadia Healthcare Company, Inc. $ACHC Stake Lessened by Rock Springs Capital Management LP

Rock Springs Capital Management LP cut its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 37.1% during the 1st quarter, HoldingsChannel reports. The fund owned 75,500 shares of the company’s stock after selling 44,500 shares during the period. Rock Springs Capital Management LP’s holdings in Acadia Healthcare were worth $1,766,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. increased its position in shares of Acadia Healthcare by 417.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the last quarter. Jefferies Financial Group Inc. bought a new position in shares of Acadia Healthcare during the fourth quarter worth about $47,960,000. Wellington Management Group LLP grew its stake in Acadia Healthcare by 24.9% in the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after purchasing an additional 2,350,760 shares in the last quarter. Vaughan Nelson Investment Management L.P. bought a new stake in Acadia Healthcare in the first quarter valued at about $43,017,000. Finally, Invenomic Capital Management LP raised its stake in Acadia Healthcare by 71.0% during the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock valued at $46,998,000 after buying an additional 1,375,647 shares in the last quarter.

Analyst Ratings Changes

A number of research firms have commented on ACHC. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. UBS Group upped their price target on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Cantor Fitzgerald raised their price objective on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Guggenheim lifted their price objective on shares of Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research note on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $28.69.

Acadia Healthcare Stock Down 5.8%

NASDAQ:ACHC opened at $32.50 on Tuesday. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The stock has a 50 day moving average of $27.78 and a 200-day moving average of $23.36. The firm has a market capitalization of $2.99 billion, a PE ratio of -2.66, a price-to-earnings-growth ratio of 11.51 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business’s revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the business posted $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Analysts predict that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.